Loading...

Swedish Orphan Biovitrum AB (publ)

BIOVF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$39.87
$0.00(0.00%)
U.S. Market opens in 12h 38m

Swedish Orphan Biovitrum AB (publ) (BIOVF) Stock Overview

Explore Swedish Orphan Biovitrum AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.8B
P/E Ratio255.56
EPS (TTM)$0.15
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$35.69
3 Months$36.96
1 Year Target$36.11

BIOVF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Swedish Orphan Biovitrum AB (publ) (BIOVF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $36.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 255.56 and a market capitalization of 13.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-3.51%
3-Month Change
7.76%
6-Month Change
19.73%
Year-to-Date (YTD) Change
13.11%
1-Year Change
48.22%
3-Year Change
51.02%
5-Year Change
140.04%
All-Time (Max) Change
106.26%

Contact Information

https://www.sobi.com
46 86 97 20 00
Tomtebodavägen 23A, Solna, NaN, 112 76

Company Facts

1,895 Employees
IPO DateJan 8, 2021
CountrySE
Actively Trading

Frequently Asked Questions